Your browser doesn't support javascript.
loading
MicroRNA profiling identifies miR-7-5p and miR-26b-5p as differentially expressed in hypertensive patients with left ventricular hypertrophy
Kaneto, CM; Nascimento, JS; Moreira, MCR; Ludovico, ND; Santana, AP; Silva, RAA; Silva-Jardim, I; Santos, JL; Sousa, SMB; Lima, PSP.
  • Kaneto, CM; Universidade Estadual de Santa Cruz. Departamento de Ciências Biológicas. Ilhéus. BR
  • Nascimento, JS; Universidade Estadual de Santa Cruz. Departamento de Ciências Biológicas. Ilhéus. BR
  • Moreira, MCR; Universidade Estadual de Santa Cruz. Departamento de Ciências Biológicas. Ilhéus. BR
  • Ludovico, ND; Universidade Estadual de Santa Cruz. Departamento de Ciências Biológicas. Ilhéus. BR
  • Santana, AP; Universidade Estadual de Santa Cruz. Departamento de Ciências Biológicas. Ilhéus. BR
  • Silva, RAA; Universidade Estadual de Santa Cruz. Departamento de Ciências Biológicas. Ilhéus. BR
  • Silva-Jardim, I; Universidade Estadual de Santa Cruz. Departamento de Ciências Biológicas. Ilhéus. BR
  • Santos, JL; Universidade Estadual de Santa Cruz. Departamento de Ciências Biológicas. Ilhéus. BR
  • Sousa, SMB; Universidade Estadual de Santa Cruz. Departamento de Ciências Biológicas. Ilhéus. BR
  • Lima, PSP; Universidade Estadual de Santa Cruz. Departamento de Ciências Biológicas. Ilhéus. BR
Braz. j. med. biol. res ; 50(12): e6211, 2017. tab, graf
Article in English | LILACS | ID: biblio-888961
ABSTRACT
Recent evidence suggests that cell-derived circulating miRNAs may serve as biomarkers of cardiovascular diseases. However, a few studies have investigated the potential of circulating miRNAs as biomarkers for left ventricular hypertrophy (LVH). In this study, we aimed to characterize the miRNA profiles that could distinguish hypertensive patients with LHV, hypertensive patients without LVH and control subjects, and identify potential miRNAs as biomarkers of LVH. LVH was defined by left ventricular mass indexed to body surface area >125 g/m2 in men and >110 g/m2 in women and patients were classified as hypertensive when presenting a systolic blood pressure of 140 mmHg or more, or a diastolic blood pressure of 90 mmHg or more. We employed miRNA PCR array to screen serum miRNAs profiles of patients with LVH, essential hypertension and healthy subjects. We identified 75 differentially expressed miRNAs, including 49 upregulated miRNAs and 26 downregulated miRNAs between LVH and control patients. We chose 2 miRNAs with significant differences for further testing in 59 patients. RT-PCR analysis of serum samples confirmed that miR-7-5p and miR-26b-5p were upregulated in the serum of LVH hypertensive patients compared with healthy subjects. Our findings suggest that these miRNAs may play a role in the pathogenesis of hypertensive LVH and may represent novel biomarkers for this disease.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Hypertrophy, Left Ventricular / MicroRNAs / Hypertension Type of study: Etiology study / Observational study / Prognostic study / Risk factors Limits: Adult / Aged / Female / Humans / Male Language: English Journal: Braz. j. med. biol. res Journal subject: Biology / Medicine Year: 2017 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade Estadual de Santa Cruz/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Hypertrophy, Left Ventricular / MicroRNAs / Hypertension Type of study: Etiology study / Observational study / Prognostic study / Risk factors Limits: Adult / Aged / Female / Humans / Male Language: English Journal: Braz. j. med. biol. res Journal subject: Biology / Medicine Year: 2017 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade Estadual de Santa Cruz/BR